Predictive value of cardiac magnetic resonance atrial and ventricular strain for adverse prognosis in patients with myocarditis: a systematic review and meta-analysis Authors: Meiling Li, Yongxia Zhou, Wei Zhou, Jie Ying, Dan Liu Published: 2026 ABSTRACT AbstractBackgroundMyocarditis refers to an inflammatory response of myocardial tissue caused by various causes. Patients with myocarditis are at high risk of adverse prognosis, defined as major adverse cardiac events (MACEs). Atrial and ventricles strain analysis using cardiac magnetic resonance (CMR) plays a crucial role in the prognostic evaluation of myocarditis. This meta-analysis provides the first comprehensive evaluation of the predictive value of atrial and ventricular strain derived from CMR for MACE in patients with myocarditis.MethodsWe searched PubMed, Embase, Web of Science, Cochrane Library, OVID Medline, Scopus, Sinomed, CNKI, Wanfang Data, VIP Database, and the search time range spans from the establishment of the database to June 2026. The level of evidence was assessed based on meta-analyses of the hazard ratios (HR) and 95% confidence intervals (CIs) of atrial and ventricular strain parameters for predicting MACE. Fixed-effect or random-effect models were used to synthesize data, with I2 and sensitivity analyses for heterogeneity.ResultsA total of 18 studies involving 3,454 participants were included, comprising 15 studies on left ventricular (LV) strain, 8 on right ventricular (RV) strain, and 8 on left atrial (LA) strain. Regarding LV myocardial strain, global longitudinal strain (GLS) (HR 1.22, 95% CI: 1.13–1.31), global circumferential strain (GCS) (HR 1.18, 95% CI: 1.10–1.28), and global radial strain (GRS) (HR 0.91, 95% CI: 0.86–0.95) all showed prognostic value for MACE in acute myocarditis. The timing of magnetic resonance (MR) examination is critical, and imaging appears to be most informative when performed within 2 weeks, or even within 1 week, after symptom onset. Regarding LA myocardial strain, Ԑs (HR 0.89, 95% CI: 0.83–0.96) and Ԑe (HR 0.92, 95% CI: 0.88–0.96) showed prognostic value for MACE in both acute and chronic myocarditis. In contrast, RV strain parameters showed limited prognostic value for MACE.ConclusionsLA and LV strain derived from CMR are associated with MACEs in patients with myocarditis. Incorporating myocardial strain into the management of myocarditis may improve risk stratification.Keywords: Myocarditis, cardiac magnetic resonance (CMR), atrial and ventricular strain, major adverse cardiac event (MACE), meta-analysis Introduction Myocarditis refers to an inflammatory response of myocardial tissue caused by various causes. Myocarditis has complex causes and presents with diverse clinical manifestations. Patients with myocarditis are at high risk of adverse prognosis, defined as major adverse cardiac event (MACE). The majority of the literature indicates that the incidence of MACE among patients with myocarditis reaches over 10% or even higher (1,2). Early prediction and intervention are crucial for improving prognosis. In recent years, cardiac magnetic resonance (CMR) has emerged as a widely utilized tool for the non-invasive diagnosis and risk stratification of myocarditis, serving as the non-invasive “gold standard” for its clinical diagnosis (3-5). Cardiac magnetic resonance feature tracking (CMR-FT) technology has demonstrated high sensitivity in detecting myocardial microstructural damage. CMR-FT myocardial strain enables quantitative analysis of myocardial deformation and contractile function, and can detect early myocardial dysfunction that conventional indices such as left ventricular ejection fraction (LVEF) fail to identify. Even among patients with preserved ejection fraction (EF), a notable decrease in myocardial strain can be detected (6). CMR-FT carries important value in prognostic assessment of myocarditis, especially in early diagnosis and risk stratification (1). CMR-FT strain parameters can be measured on standard cine sequences without additional acquisition or contrast injection. Although some controversies exist in current studies, its clinical value will be further validated and expanded with technological advances and deeper research (7). It is well-established that late gadolinium enhancement (LGE) on MRI and LVEF serve as predictive factors for MACE in patients with myocarditis (8,9). Previous research has demonstrated that CMR-FT analysis constitutes an independent and incremental prognostic biomarker for forthcoming cardiovascular events, with global longitudinal strain (GLS) exhibiting superior predictive value compared to both clinical and CMR characteristics, encompassing LVEF and LGE (2,10). However, there are numerous strain parameters in each atrium and ventricle, and the predictive value of strain parameters for MACE varies across studies, which may be related to sample size, patient population, and timing of CMR examination. To date, no related meta-analysis has been published. Therefore, this study mainly intends to perform a systematic review and meta-analysis of atrial and ventricular strain derived from CMR-FT in predicting MACE of patients with myocarditis. We present this article in accordance with the PRISMA reporting checklist (11) (available at https://qims.amegroups.com/article/view/10.21037/qims-2026-1012/rc). Methods This systematic review and meta-analysis was registered in INPLASY (INPLASY202610091). Search strategy Two independent investigators conducted a systematic search of PubMed, Embase, Web of Science, Cochrane Library, OVID Medline, Scopus, Sinomed, CNKI, Wanfang Data, VIP Database, and the search time range spans from the establishment of the database to June 2026. Keywords and search terms used in the search included myocarditis (myocarditis OR Myocarditides OR Carditis OR myocardial inflammation) AND CMR (CMR OR MRI OR resonance imaging) AND prognosis (prognosis OR prognostic OR predictive value OR risk assessment OR outcome OR factor OR predictor OR Independent prediction) AND strain (Figure 1). Literature search process and results. Study selection The detailed inclusion criteria were as follows: (I) type of study: prospective and retrospective cohort study. Studies including patients with myocarditis or clinically suspected myocarditis. The diagnosis of myocarditis is based on the 2013 guidelines of the European Society of Cardiology (ESC) (12) and is confirmed by CMR. Clinically suspected myocarditis (according to the 2013 ESC guidelines) refers to symptomatic patients presenting with dyspnea, chest pain, palpitations, or other relevant cardiac symptoms who satisfy one or more diagnostic criteria (elevated troponin, abnormal electrocardiography, and functional or structural abnormalities confirmed by echocardiography or CMR) and asymptomatic patients who satisfy two or more of the above-mentioned criteria. (II) The topic is to use CMR-FT derived atrial and ventricular strain to predict MACE in patients with myocarditis; (III) the mean time of follow-up more than one year; (IV) MACE, including life threatening arrhythmias, death, heart failure, rehospitalization because of recurrence or a cardiac event, heart transplantation, implanted cardioverter-defibrillator or pacemaker, atrial fibrillation, embolic stroke or cardiac stroke, cardiac shock, dilated cardiomyopathy. We excluded the following articles: (I) review, conference summary, editorial, case report and meta-analysis; (II) studies on myocardial strain measurement based on echocardiography; (III) studies without reporting of clinical prognosis. After deleted any duplicate study, two reviewers independently reviewed the abstract and full text to assess the eligibility of all studies by an unblinded, standardised manner according to the inclusion and exclusion criteria. Any disagreement was resolved by consulting by a third reviewer. Data extraction and quality assessment Two researchers extracted and crosschecked the data using a self-made extraction table. If any disagreement arose, a third reviewer was consulted. The extracted data included the first author, year of publication, study design, MR equipment, number of participants, age, sex, timing of MR examination, presence of LGE, LVEF, RVEF, follow-up period, number of MACEs, and left ventricular (LV), right ventricular (RV), and left atrial (LA) strain parameters, including hazard ratios (HRs) and confidence intervals (CIs). LV strain parameters included GLS, global circumferential strain (GCS), and global radial strain (GRS). LA strain parameters mainly included reservoir strain (Ԑs), conduit strain (Ԑe), booster strain (Ԑa), and strain rate parameters [systolic peak strain rate (SRs), early diastolic peak strain rate (SRe), and late diastolic peak strain rate (SRa)]. Regarding study quality evaluation indicators, all the reported HR values represent the increased risk of outcome events associated with a one-unit increase in the parameter and were adjusted for relevant covariates. Quality In Prognosis Studies (QUIPS) was used to evaluate the quality of the included studies (13). QUIPS consists of six domains: study participation, study attrition, prognostic factor measurement, outcome measurement, study confounding, and statistical analysis and reporting. Each QUIPS domain was rated as high, moderate, or low risk. The overall risk of bias for each study was defined as low if five or more domains were rated as low risk, moderate if three to four domains were rated as low risk, and high if two or fewer domains were rated as low risk. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was used to assess the pooled results and enhance evidence transparency (14). Statistical analysis Statistical analysis was conducted using RevMan 5.3 software. The risk ratio (HR) was used as the effect size for the analysis, and its 95% confidence interval was provided. We evaluated heterogeneity using the I2-statistic. I2 >50% and Q‐test P<0.1 indicated statistically significant heterogeneity. When moderate to significant heterogeneity (P<0.1) exists among studies, a random-effects model was implemented. Fixed‐effects models was used when the degree of statistical heterogeneity was low. A “one study removed” sensitivity analysis was performed to assess the relative impact of each outcome on the pooled HR and between-study variability. Results The initial search yielded a total of 1,470 documents. After multiple rounds of screening, 18 studies were ultimately selected. The process and results of literature screening are shown in Figure 1. Seventeen articles were retrospective cohort studies, and 1 article was a prospective cohort study. The basic characteristics of the included studies are presented in Tables 1,2. LV strain parameters (including global longitudinal, circumferential, and radial strain) and LA strain parameters (Ԑs and Ԑe) were impaired in the MACE subgroup compared with all patients (Table 3). Table 2 shows the specific lesions of MACE and the detailed prognostic factors. Table 4 presents the QUIPS evaluation results for the 18 studies. The overall risk of bias was low to moderate. Table 1Characteristics of included studiesStudyMyocarditis/suspected myocarditisCountryNo. of patientsAge (yr)Male (%)CMR equipment (T)LGE+ (%)LVEF (%)RVEF (%)Follow-up, yNo. of MACELee JW, et al. (7) (2017)Suspected myocarditisKorea3741.5±17.5591.5 or 362.245.8±17.150.8±14.23.411 (29.7)Fischer K, et al. (15) (2020)MyocarditisSwitzerland45549±16.0591.5 or 36546.4±15.8NR3.974 (16)Chen Y, et al. (16) (2022)Suspected myocarditisChina10820 [15]7534061.26±6.3252.69±9.081.518 (16.67)Vos JL, et al. (17) (2022)MyocarditisNetherlands16240 [27]71.59051±1253±95.529 (18)Motevalli M, et al. (18) (2022)MyocarditisIran13337±1674.41.510041±1446±132.616 (12.03)Porcari A, et al. (10) (2022)MyocarditisItaly25636 [25]711.569.560 [7]NR2.324 (9)Lee J, et al. (19) (2023)MyocarditisKorea4744.2±18.3621.5 or 385.145.7±18.351.3±5.23.120 (42.6)Chen Y, et al. (20) (2023)Suspected myocarditisChina5515 [10]69.1350.9156.33±13.9947.05±12.751.216 (29.1)Soeiro AM, et al. (21) (2023)MyocarditisBrazil10037.9±18.180.41.59657.553.01.626 (26)Bernhard B, et al. (22) (2023)Suspected myocarditisSwitzerland65948.1±16.162.81.5 or 37748.4±15.147.9±11.83.7115 (17.6)Cau R, et al. (1) (2024)MyocarditisSwitzerland14141±20791.54956 [11]55.7 [6.7]1.917 (12)Bernhard B, et al. (2) (2024)Suspected myocarditisSwitzerland69048.0±16.0621.5 or 364.149.1±15.0NR3.8116 (16.8)Chen Y, et al. (23) (2025)Suspected myocarditisChina16518 [14]70.9355.260.95±6.22NR2.523 (13.37)Chen Y, et al. (24) (2025)MyocarditisChina9134.9±18.6563NR50.0±15.2NR113 (14.3)Zou Y, et al. (25) (2026)Suspected myocarditisChina11346±1454.93NRNRNR117 (15)Chen Y (26) (2026)MyocarditisChina5039.5611.5NRNRNR616 (32)Huang M (27) (2026)MyocarditisChina14626±1648.61.5 or 354.860.9±5.450.8±8.76.936 (24.7)Ren R (28) (2026)Suspected myocarditisChina463067.31.552NRNR2.111 (23.91)Data are presented as n (%), median [interquartile range] or mean ± standard deviation. CMR, cardiac magnetic resonance; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; NR, not reported; RVEF, right ventricular ejection fraction. Characteristics of included studies Data are presented as n (%), median [interquartile range] or mean ± standard deviation. CMR, cardiac magnetic resonance; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; NR, not reported; RVEF, right ventricular ejection fraction. Table 2The characteristics included in the study and the related prognostic informationStudyAcute or chronicMR examination timePrognostic factors (myocardial strain)Other prognostic factorsMACELV strainRV strainLA strainLGELVEFHFDeathVARecurrence or rehospitalization due to cardiac eventsOthers (HT, ICD/PM, AF, ES/CS, CS, DCM, LVEF <50%)Lee JW, et al. (7) (2017)Acute11.6±8.5 days after symptom onset③NRNRThe presence of LGENR02045Fischer K, et al. (15) (2020)AcuteWithin 2 weeks after symptom onset①NRNRLGE extent+32322000Chen Y, et al. (16) (2022)Acute and chronic42 [18–97] daysNo①NRNoNo71073Vos JL, et al. (17) (2022)Acute6 [3–9] days after admission①②③NoNoNoNo7171101Motevalli M, et al. (18) (2022)AcuteNR①NoNRNo+030014Porcari A, et al. (10) (2022)Acute4 [2–12] days after admission①NRNRSubepicardial LGENR124017Lee J, et al. (19) (2023)Acute13.5±9.7 days after symptom onsetNRNR④⑤No+04079Chen Y, et al. (20) (2023)Acute and chronic19 (7,53) days after symptom onsetNoNo⑦NoNo011140Soeiro AM, et al. (21) (2023)Acute1.5 days after symptom onset①②③NoNRNoNo2020170Bernhard B, et al. (22) (2023)Acute10 [4–28] days after symptom onset①NoNRLV LGE extentNo454233160Cau R, et al. (1) (2024)Acute4.1±2.6 days after admission①②③NR④⑥LGE septal+001700Bernhard B, et al. (2) (2024)NrNR①NRNRLGE extentNo402929180Chen Y, et al. (23) (2025)Acute and chronic35 [15–75] daysNoNR⑤NoNo101093Chen Y, et al. (24) (2025)AcuteNRNRNRUnivariate analysisNRNR64102Zou Y, et al. (25) (2026)Chronic>1 monthNRNR④⑤NoNo74420Chen Y (26) (2026)AcuteNR①③NoNRNRNo70540Huang M (27) (2026)In-hospital convalescent phaseNR③NoNRNoNR620235Ren R (28) (2026)AcuteNRNoNRNoNoNo3044The table shows details of the studies included in the meta-analysis. Values are mean or mean ± SD, median (IQR) or median [Q1–Q3]. ① GLS; ② GCS; ③ GRS; ④ LA Ԑs; ⑤ LA Ԑe; ⑥LA Ԑa; ⑦ peak late negative strain rate, SRa. Ԑa, booster strain; AF, atrial fibrillation; CS, cardiac shock; DCM, dilated cardiomyopathy; Ԑe, conduit strain; ES, embolic stroke; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; HF, heart failure; HT, heart transplantation; ICD/PM, implanted cardioverter-defibrillator/pacemaker; IQR, interquartile range; LA, left atrial; LGE, late gadolinium enhancement; LV, left ventricular; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; MR, magnetic resonance; NR, not reported; RV, right ventricular; Ԑs, reservoir strain; SD, standard deviation; SRa, late diastolic peak strain rate; VA, ventricular arrhythmia. The characteristics included in the study and the related prognostic information The table shows details of the studies included in the meta-analysis. Values are mean or mean ± SD, median (IQR) or median [Q1–Q3]. ① GLS; ② GCS; ③ GRS; ④ LA Ԑs; ⑤ LA Ԑe; ⑥LA Ԑa; ⑦ peak late negative strain rate, SRa. Ԑa, booster strain; AF, atrial fibrillation; CS, cardiac shock; DCM, dilated cardiomyopathy; Ԑe, conduit strain; ES, embolic stroke; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; HF, heart failure; HT, heart transplantation; ICD/PM, implanted cardioverter-defibrillator/pacemaker; IQR, interquartile range; LA, left atrial; LGE, late gadolinium enhancement; LV, left ventricular; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; MR, magnetic resonance; NR, not reported; RV, right ventricular; Ԑs, reservoir strain; SD, standard deviation; SRa, late diastolic peak strain rate; VA, ventricular arrhythmia. Table 3Strain parameter values of LV (GLS, GCS, GRS) and LA (Ԑs, Ԑe)StudyGLS, %GCS, %GRS, %LA Ԑs, %LA Ԑe, %All patientsMACE (+) subgroup/cut-off valueAll patientsMACE (+) subgroup/cut-off valueAll patientsMACE (+) subgroup/cut-off valueAll patientsMACE (+) subgroup/cut-off valueAll patientsMACE (+) subgroup/cut-off valueLee JW, et al. (7) (2017)−10.58±4.76NR−9.53±4.87NR19.13±8.88NR/9.48NRNRNRNRFischer K, et al. (15) (2020)−12.5±4.5NR/−13.1−13.4±5.3NR21.0±10.8NRNRNRNRNRChen Y, et al. (16) (2022)−10.48±3.17NR/−12.05−19.49±3.60NR32.14±10.12NRNRNRNRNRVos JL, et al. (17) (2022)−21±6−17±6/−18−26±8−22±8/−2252±1842±20/NR35±1130±12/3019±915±7/11Motevalli M, et al. (18) (2022)−11.5−7.39 (−7)/−9−13.5−7.24 (−10)/NR27.7±13.912.95 (23)/NRNRNRNRNRPorcari A, et al. (10) (2022)−17.3 [−19.5 to −15.4]−13.9 [−15.6 to −9.7]/−20NRNRNRNRNRNRNRLee J, et al. (19) (2023)−12.8±7.0−8.5±5.4/NRNRNRNRNR23.7±14.213.5±9.1/19.914.1±11.07.5±6.5/11.1Chen Y, et al. (20) (2023)−10.13 (−12.06, −6.98)NR−17.75±5.27NR28.94±12.88NR20.70 (12.90, 25.90)NR11.80 (7.30, 18.30)NRSoeiro AM, et al. (21) (2023)−13.4±3.8NR/−12.3−14.5 (−17.3)NR/−14.523.2±8.2NR/19.9NRNRNRNRBernhard B, et al. (22) (2023)−12.9±4.5NR−14.3±5.3NR22.8±10.9NRNRNRNRNRCau R, et al. (1) (2024)−13.9 (−15.5, −12.1)−9.3 (−12.2, −8.3)/NR−14.4 (−17.0, −12.2)−11.1 (−13.6, −9.3)/−13.322 (18,29)16 (13,20) /NR30 (24,38)20 (10,29)/NR18 (12,23)8 (5,15)/NRBernhard B, et al. (2) (2024)−13.1±4.4NRNRNRNRNRNRNRNRNRChen Y, et al. (23) (2025)−10.74±2.98−10.04±3.01/NR−19.12±3.88−17.75±4.57/NR31.47±10.0230.98±10.02/NR25.5 (18.2, 33.25)21.1 (12.5, 27.2)/NR15.95 (10.00, 21.73)10.2 (6.3, 18.0)/10.4Chen Y, et al. (24) (2025)−14.6±4.3−12.1±4.1/NRNRNRNRNR41.7 (22.0, 62.9)20.6 (9.9, 33.1)/25.621.1 (11.0, 34.7)10.5 (4.7, 13.0)/NRZou Y, et al. (25) (2026)NRNRNRNRNRNRNR11.9 (9.2–19.0) /24.9NR6.7 (4.3–8.9)/11.1Chen Y (26) (2026)NR−9.01±4.45/−10.96NR−13.04±4.02NR17.77±10.19/17.28NRNRNRNRHuang M (27) (2026)−15.5±4.7−15.5±2.9/NR−19.5±3.7−19.0±3.2/NR39.1±14.133.9±10.7/37NRNRNRNRRen R (28) (2026)NR−9.16±3.03NR−8.7 (−14.3, −6.6)NR13.8 (8.3, 21.7)NR18.2 (15.2, 20.6)NR8.6 (5.8, 12.0)Values are mean or mean ± SD, median [range] or median (IQR). The cut-off value serves as the demarcation point to distinguish between patients at high risk and low risk of MACE occurrence. Ԑe, conduit strain; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; IQR, interquartile range; LA, left atrial; LV, left ventricular; MACE, major adverse cardiac event; NR, not reported; Ԑs, reservoir strain; SD, standard deviation. Strain parameter values of LV (GLS, GCS, GRS) and LA (Ԑs, Ԑe) Values are mean or mean ± SD, median [range] or median (IQR). The cut-off value serves as the demarcation point to distinguish between patients at high risk and low risk of MACE occurrence. Ԑe, conduit strain; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; IQR, interquartile range; LA, left atrial; LV, left ventricular; MACE, major adverse cardiac event; NR, not reported; Ԑs, reservoir strain; SD, standard deviation. Table 4Risk of bias in prognostic researchStudyStudy participationStudy attritionPrognostic factor measurementOutcome measurementStudy confoundingStatistical analysis and reportingLee JW, et al. (7) (2017)LowLowLowLowLowLowFischer K, et al. (15) (2020)LowLowLowLowLowLowChen Y, et al. (16) (2022)ModerateLowLowLowLowLowVos JL, et al. (17) (2022)LowLowLowLowModerateLowMotevalli M, et al. (18) (2022)LowLowLowLowLowModeratePorcari A, et al. (10) (2022)ModerateLowLowModerateLowLowLee J, et al. (19) (2023)LowLowLowLowLowLowChen Y, et al. (20) (2023)LowLowLowLowLowLowSoeiro AM, et al. (21) (2023)LowLowLowLowLowLowBernhard B, et al. (22) (2023)LowLowLowLowLowLowCau R, et al. (1) (2024)LowLowLowLowLowLowBernhard B, et al. (2) (2024)LowLowLowLowLowLowChen Y, et al. (23) (2025)ModerateLowLowLowLowLowChen Y, et al. (24) (2025)LowLowLowLowModerateLowZou Y, et al. (25) (2026)LowLowLowLowLowLowChen Y (26) (2026)LowLowLowLowModerateLowHuang M (27) (2026)ModerateModerateLowLowLowLowRen R (28) (2026)LowLowLowLowModerateLow Risk of bias in prognostic research Predictive value of LV myocardial strain for MACE The association between LV myocardial strain and MACE was assessed in 15 studies (1,2,7,10,15-18,20-23,26-28). Eleven studies confirmed the prognostic value of LV strain parameters for MACE in myocarditis. Three studies (20,23,28) reported that none of the LV strain parameters, including GLS, GCS, and GRS, could predict MACE. One study (16) concluded that GLS had prognostic value only in the LGE-positive subgroup. Among the 15 studies, 9 reported that GLS had prognostic value, 3 reported that GCS had prognostic value, and 6 reported that GRS had prognostic value. The relevant parameter values are shown in Tables 1-3. Three studies (1,17,21) identified all LV strain parameters, including GLS, GCS, and GRS, as prognostic factors. Across these studies, the number of included cases ranged from 100 to 162, the mean age ranged from 37.9 to 41 years, and the proportion of male participants ranged from 75% to 80.4%. The LGE positivity rate ranged from 49% to 96%, and mean LVEF ranged from 51% to 57.5%. The follow-up period ranged from 1.6 to 5.5 years, and the incidence of MACE ranged from 12% to 26%. The median timing of MR examination ranged from 1.5 to 6 days after symptom onset or admission. GLS Nine studies (1,2,10,15,17,18,21,22,26) identified GLS as a prognostic factor. Only the literature specifically targeting CMR-proven acute myocarditis were included for the meta-analysis. Exclude one article due to the significant difference in MACE compared to other studies, and the inclusion criteria were “LVEF preservation”. A total of 6 articles were finally included (1,15,17,18,21,26), involving a total of 1,041 cases. The mean age ranged from 37 to 49 years, the LGE positivity rate ranged from 49% to 100%, and mean LVEF ranged from 41% to 57.5%. The follow-up period ranged from 1.6 to 6 years, and the incidence of MACE ranged from 12% to 32%. Specifically, MACE included 66 cases of heart failure, 54 deaths, 53 cases of ventricular arrhythmia, 21 cases of recurrence or rehospitalization due to cardiac events, and 15 other events. GLS showed particularly strong prognostic value for heart failure, death, and ventricular arrhythmia. The meta-analysis showed substantial heterogeneity across the 6 studies (I²=84%). Because significant heterogeneity persisted, a sensitivity analysis was performed. This analysis identified studies by Marzieh M (2022) and Jacqueline L (2022) (17,18) as the main source of heterogeneity, and these studies were therefore excluded. In the meta-analysis of the remaining four studies, between-study heterogeneity was not statistically significant (I²=0%, P=0.71), and a fixed-effects model was therefore applied. The pooled results showed that for each 1% worsening in GLS, the risk of MACE increased by 22% (HR 1.22, 95% CI: 1.13–1.31, Z=5.03, P<0.05; Figure 2A). Forest plot of HR of (A) GLS, (B) GCS, and (C) GRS. CI, confidence interval; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; HR, hazard ratio; SE, standard error. GCS Three studies (1,17,21) identified GCS as a prognostic factor, involving a total of 403 cases. All study populations consisted of patients with acute myocarditis. The median timing of MR examination ranged from 1.5 to 6 days after symptom onset or admission. MACE included 27 cases of heart failure, 19 deaths, 28 cases of ventricular arrhythmia, 17 cases of recurrence or rehospitalization due to cardiac events, and 1 other event. In the meta‐analysis of the three studies, the heterogeneity between studies were not statistically significant (I2=0%, P=0.42), so the fixed‐effects model was used for meta analysis. The meta‐analysis results showed that for each 1% worsening in GCS, the risk of MACE increased by 18% (HR 1.18, 95% CI: 1.10–1.28, Z=4.23, P<0.05; Figure 2B). Sensitivity analysis showed that removal of any single study did not materially affect the pooled results, indicating that the fixed-effects model results were stable and reliable. GRS Six studies (1,7,17,21,26,27) identified GRS as a prognostic factor. Excluding two articles because their inclusion criteria were “in-hospital convalescent phase” and “suspected myocarditis”. Only the literature specifically targeting CMR-proven acute myocarditis were included for the meta-analysis. A total of 4 articles were finally included (1,17,21,26), involving a total of 453 cases. Mean age ranged from 37.9 to 41 years, the LGE positivity rate ranged from 49% to 96%, and mean LVEF ranged from 51% to 57.5%. The follow-up period ranged from 1.6 to 6 years, and the incidence of MACE ranged from 12% to 32%. MACE included 34 cases of heart failure, 19 deaths, 33 cases of ventricular arrhythmia, 21 cases of recurrence or rehospitalization due to cardiac events, and 1 other events. Meta-analysis of these four studies using a random-effects model showed substantial heterogeneity (I²=67%). Because significant heterogeneity was present, a sensitivity analysis was performed. The analysis indicated that the study by Jacqueline L (2022) (17) was the main source of heterogeneity, and this study was excluded. In the meta-analysis of the remaining three studies, between-study heterogeneity was not statistically significant (I²=0%, P=0.85), and a fixed-effects model was therefore applied. The pooled results showed that for each 1% increase in GRS, the risk of MACE decreased by 9% (HR 0.91, 95% CI: 0.86–0.95, Z=3.91, P<0.05; Figure 2C). Regarding GRADE evidence assessment, the comprehensive assessment revealed that the certainty of evidence related to the prognostic value of GLS, GCS, and GRS was high. Predictive value of LA myocardial strain for MACE The association between LA myocardial strain and MACE was assessed in 8 studies (1,17,19,20,23,24,28). Of these, six supported its prognostic value for MACE, whereas two did not. One study reported only univariable analysis, and the data were unavailable; therefore, the remaining five studies were included in the meta-analysis. Three studies reported that εs had prognostic value, three reported that εe had prognostic value, one reported that εa had prognostic value, and one reported that SRa had prognostic value. The relevant parameter values are shown in Table 3. LA Ԑs Three studies (1,19,25) identified Ԑs as a prognostic factor, involving a total of 301 cases. Two studies included patients with acute myocarditis, whereas one included patients with chronic myocarditis. Mean age ranged from 41 to 46 years. The follow-up period ranged from 1.0 to 3.1 years, and the incidence of MACE ranged from 12% to 42.6%. MACE included 7 cases of heart failure, 8 deaths, 21 cases of ventricular arrhythmia, 9 cases of recurrence or rehospitalization due to cardiac events, and 9 other events. In the meta‐analysis of the three studies, the results indicated moderate heterogeneity (I2=50%, P=0.13), so the random-effects model was used for meta analysis. The pooled results were as follows: HR 0.89 (95% CI: 0.83–0.96), Z=3.09, P<0.05 (Figure 3A). Forest plot of HR of (A) Ԑs, (B) Ԑe. CI, confidence interval; Ԑe, conduit strain; HR, hazard ratio; Ԑs, reservoir strain; SE, standard error. LA Ԑe Three studies (19,23,25) identified Ԑe as a prognostic factor, involving a total of 325 cases. One study focused on acute myocarditis, one included both acute and chronic myocarditis, and one focused on chronic myocarditis. Mean age ranged from 18 to 46 years. The follow-up period ranged from 1.0 to 3.1 years, and the incidence of MACE ranged from 13.37% to 42.6%. MACE included 17 cases of heart failure, 9 deaths, 4 cases of ventricular arrhythmia, 18 cases of recurrence or rehospitalization due to cardiac events, and 12 other events. In the meta‐analysis of the three studies, the results indicated moderate heterogeneity (I2=44%, P=0.17), and fixed‐effects model was used for meta analysis. The pooled results were as follows: HR 0.92 (95% CI: 0.88–0.96), Z=3.70, P<0.05 (Figure 3B). Regarding GRADE evidence assessment, the comprehensive assessment revealed that the certainty of evidence related to the prognostic value of Ԑs and Ԑe was moderate. Predictive value of RV myocardial strain for MACE The association between RV myocardial strain and MACE was assessed in 8 studies (16-18,20-22,26,27). Seven studies found no predictive value of RV GLS for MACE in myocarditis, while only one confirmed prognostic value of RV-GLS in suspected myocarditis patients with preserved LVEF, mainly in the patients with chronic myocarditis (16). One study (22) showed that RV-GLS predicted heart failure of patients with myocarditis but has limited value for overall MACE. Prognostic value of LGE and LVEF, and their relationship with myocardial strain Among the 15 studies that reported LVEF, 4 (1,15,18,19) concluded that LVEF was a predictive factor for MACE, with mean LVEF ranging from 41% to 56%. Among the six studies with mean LVEF <50%, four concluded that only GLS had prognostic value, one concluded that only GRS had prognostic value, and one did not evaluate LV strain. Among the 16 studies that reported LGE, 6 (1,2,7,10,15,22) identified LGE as a predictive factor for MACE, including LGE positivity rate, location, and extent. In these six studies, the LGE positivity rate ranged from 49% to 77%. In contrast, all four studies with an LGE positivity rate > 80% concluded that LGE had no predictive value. Among these four studies, three reported that GLS had prognostic value, two reported that GRS and GCS had prognostic value, and one provided unclear results because no multivariable analysis was reported. Another study that included patients with myocarditis and preserved EF showed that LV GLS had prognostic value only in the LGE-positive subgroup. Discussion CMR-FT plays an important role in the follow-up of patients with myocarditis (6). This meta-analysis is the first to comprehensively evaluate the association of both atrial and ventricular strain parameters with MACE. The key findings were as follows: (I) regarding LV myocardial strain, GLS (HR 1.22, 95% CI: 1.13–1.31), GCS (HR 1.18, 95% CI: 1.10–1.28), and GRS (HR 0.91, 95% CI: 0.86–0.95) all showed prognostic value for MACE in acute myocarditis. In the patient group with a higher positive rate of LGE and a lower average LVEF, this may offer greater value. The three studies that identified prognostic value for GLS, GCS, and GRS all reported that the median timing of MR examination was within 1 week after symptom onset or hospital admission. This finding highlights the importance of MR timing. (II) Regarding LA myocardial strain, Ԑs (HR 0.89, 95% CI: 0.83–0.96) and Ԑe (HR 0.92, 95% CI: 0.88–0.96) showed prognostic value for MACE in both acute and chronic myocarditis. Due to the limited number of included studies, further large-sample research is needed to confirm this. (III) RV strain parameters showed limited prognostic value for MACE. They may have certain predictive value for certain specific adverse outcomes (such as heart failure) or under specific conditions. Further research is needed. Some studies have concluded that both LV and atrial strain are not predictors of MACE. The reasons for this are as follows. Firstly, myocardial strain parameters are derived from CMR feature tracking, which largely depends on the best image quality and accurate endocardial boundaries. This may be affected by various factors, and the post-processing software from different manufacturers can vary, resulting in differences in measurement results. Secondly, the definition standards of MACE are not uniform, and many studies have small sample sizes, while the number of MACEs is even smaller. If the standards of MACE vary significantly, it is likely to cause different research results. Additionally, the magnetic resonance (MR) examination time in some studies is not uniform. Some studies include patients in the recovery or chronic stage of the disease, as the strain parameters gradually return to normal over time, leading to differences in prognostic value. CMR myocardial strain parameters are closely associated with MACE risk of patients with myocarditis and can serve as independent predictors for risk stratification. LV strain parameters, including GLS, GCS, and GRS, all carry prognostic value. Most literature included in this research confirmed the predictive value of GLS for adverse prognosis. The LV myocardium consists of three layers: subendocardial muscle fibers are mainly longitudinally oriented, midmyocardial muscle fibers are circumferentially oriented, and subepicardial muscle fibers are mixed helically oriented; GLS is calculated from long-axis views and reflects longitudinal shortening (from base to apex) mainly performed by subendocardial fibers; since injury to subepicardial muscle fibers and midmyocardial muscle fibers is common in patients with acute myocarditis, the injury to longitudinal subendocardial myocardial fibers may represent more severe LV myocardial involvement (18). Moreover, longitudinal contraction is the major contributor to LV output; therefore, GLS plays a key role in ventricular dysfunction. Circumferential deformation results from contraction of midmyocardial and subepicardial muscle fibers of LV myocardium, while radial deformation is determined by the three-layer myocardial structure (15,29) (Figure 4); some studies suggested that GCS provided potential incremental value relative to GLS. In patients with “suspected” or “confirmed” myocarditis, biventricular GCS was significantly impaired (30); since myocarditis often involves the subepicardial and midmyocardial muscle fibers, GCS reflects the functional status of these two layers, which may explain its greater reduction and support its role as a useful complementary tool to GLS (29). The MR examination time is critical to the patients with myocarditis. This study found that GCS, GRS, and GLS may all carry prognostic value when MRI is performed within one week of symptom onset. These parameter values may gradually recover during the course of myocarditis. Some studies suggested that the optimal examination time of MR was within 14 days of symptom onset, during which the accuracy and probability for detecting AM by CMR were highest (18,30,31). Yan Chen et al. (23) found no association between GLS and prognosis, which may be related to the high rate of negative LGE. Another study found that LV GLS had prognostic value only in LGE-positive patients (16). Although most studies supported the prognostic value of LV strain parameters, attention should be paid to the examination time of MRI and patients included in study. Left ventricular myocardial strain diagram (A, B); (C,D) show the signals of myocardial edema in the middle layer of the ventricular septum in patients with myocarditis. Written informed consent was obtained from all the patients. GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain. In recent years, LA myocardial strain has attracted extensive attention. The left atrium modulates LV filling and cardiovascular performance through three fundamental functions: reservoir, conduit, and contraction function. LA myocardial strain parameters mainly include Ԑs (corresponding to reservoir function), Ԑe (corresponding to conduit function), Ԑa (corresponding to contraction function), and strain rate parameters (SRs, SRe, SRa). LA reservoir function reflects atrial filling during LV systole and is influenced by LV contraction, LA relaxation, and atrial stiffness. The conduit function is modulated by LV relaxation and early diastolic pressure, as the LV acts as a conduit during early LV diastole and systole. LA contraction function reflects LA contraction during late diastole of LV and is modulated by LV compliance. Multiple literature included in this study showed that LA strain parameters Ԑs and Ԑe are independent predictors of MACE of patients with myocarditis (10), with comparable predictive performance. Unlike LV strain parameters, LA strain parameters carries prognostic value in both acute and chronic myocarditis. One study found that LA myocardial strain isn’t the predictive factor of MACE, possibly because MR were performed shortly after initial visit of patients (median 6 days), when structural and functional atrial remodeling hadn’t developed; thus, LA strain may become more apparent in prognostic value at later course of myocarditis (17); however, another study performed MRI at a mean of 4.1 days after admission and identified Ԑs and Ԑa as predictors of MACE (1), suggesting that LA dysfunction is not always secondary to LV dysfunction. The prognostic value of Ԑa and initial LA-SRa was reported in only one study and requires further validation. CMR-FT has the potential to reveal subclinical RV involvement in patients with acute myocarditis (32). Seven literature included in this study found no predictive value of RV GLS for MACE in myocarditis, while only one reported prognostic value of RV-GLS in suspected myocarditis patients with normal LVEF, mainly in the patients with chronic myocarditis (16). One study (22) showed that RV GLS predicted heart failure of patients with myocarditis but has limited value for overall MACE. Patients with impaired RV GLS had a longer interval from symptom onset to CMR examination compared with those with normal RV GLS. Other authors found no association between RV GLS and prognosis, possibly because most subjects had normal RV function and strain (17). Overall, the predictive value of RV GLS for MACE of myocarditis is limited. Whether it is influenced by patient population included in study and CMR examination time remains unclear and requires further investigation. Some studies showed that more CMR-FT parameters carry prognostic value when LVEF of patients with myocarditis is below 40% (15); among the literature included in this study, when mean LVEF of patient was below 50%, LV GLS was the main predictor of adverse prognosis. Among literature included in this study, four literature with LGE-positive rate >80% found no predictive value of LGE, three identified LV GLS as a predictor of adverse prognosis, while one did not report LV strain. Another study found that LV GLS had prognostic value only in LGE-positive patients. As noted by Daniela Di Lisi et al., the sum of segments with LGE was statistically correlated with lower LV GLS (33). Literature (29) has reported the LGE negative segments have preserved longitudinal strain in acute myocarditis, suggesting that the LGE negative myocardium may have a lower incidence of adverse events. Possibly because LV GLS was closely related to myocardial interstitial fibrosis (23). In conclusion, LV GLS has strong prognostic value in myocarditis, especially in patient population with low LVEF and high positive rate of LGE. Although some studies found no superior predictive value of LGE over strain, the high positive rate of LGE due to inclusion criteria of patients with myocarditis in some literature based on LGE may affect its predictive power (10). Furthermore, the extent and location of LGE often carry greater prognostic value (34). Available evidence suggests that the prognostic utility of imaging features of myocarditis may derive more from their incremental value upon comprehensive consideration rather than from individual characteristic (8,35). Limitations This study included patients with myocarditis or clinically suspected myocarditis, not all diagnosed by biopsy. Therefore, histological confirmation and etiological classification cannot be carried out. Future research should incorporate more pathological analysis to clarify the results related to the cause of the disease. In addition, this study focused on global myocardial strain parameters rather than regional strain parameters. Further exploration of the value of local myocardial strain is needed in the future. The repeatability of measurements and workflow efficiency can also be improved by combining artificial intelligence technology. Finally, due to the limited number of included studies, other subgroup or meta-regression analyses could not be conducted to explore potential sources of heterogeneity. In the future, further research could be carried out with a focus on specific demographic groups, including young individuals, elderly individuals, patients in the chronic phase, and those in the recovery phase. Additionally, CMR strain can be combined with other imaging techniques and biomarkers to gain a more comprehensive and in-depth understanding of the prognostic value of myocardial strain. Conclusions Myocardial strain measurement indirectly reflects the systolic and diastolic function of heart throughout the cardiac cycle. CMR-FT is a widely used technique without contrast agent (24), shows good reproducibility and consistency, and similar accuracy at 1.5 and 3 T, making it a very promising technology in the near future (10). CMR myocardial strain can provide robust prognostic information for patients with myocarditis. Future studies should combine CMR strain with other imaging technologies or biomarkers to establish comprehensive predictive models and improve accuracy of MACE risk prediction, conducive to doctor's formulation of individualized treatment scheme. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Footnotes Reporting Checklist: The authors have completed the PRISMA reporting checklist. Available at https://qims.amegroups.com/article/view/10.21037/qims-2026-1012/rc Funding: This work was supported by Affiliated Yongchuan Hospital of Chongqing Medical University’s In-Hospital Research Project Fund (No. YJJL2024015). Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-2026-1012/coif). The authors have no conflicts of interest to declare. References Associated Data Supplementary Materials The article’s supplementary files as